Core Viewpoint - Rosen Law Firm is reminding investors who purchased LifeMD, Inc. securities between May 7, 2025, and August 5, 2025, about the upcoming lead plaintiff deadline for a securities class action lawsuit [1]. Group 1: Class Action Details - Investors who bought LifeMD securities during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by October 27, 2025 [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. Group 2: Case Allegations - The lawsuit alleges that defendants made materially false and misleading statements regarding LifeMD's competitive position and failed to account for rising customer acquisition costs in their 2025 guidance [5]. - It is claimed that the defendants' statements about LifeMD's business operations and prospects were materially false and misleading, leading to investor damages when the true information became public [5].

Core Viewpoint - A class action lawsuit has been filed against Fluor Corporation for misleading statements regarding its financial performance and project costs during the Class Period from February 18, 2025, to July 31, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Fluor made false and misleading statements about the costs associated with several major projects, including the Gordie Howe International Bridge and various Texas highways, due to subcontractor errors, price increases, and scheduling delays [5]. - It is alleged that these issues, along with reduced customer capital spending and economic uncertainty, negatively impacted Fluor's business and financial results [5]. - The lawsuit asserts that Fluor's financial guidance for 2025 was unreliable and that the company's risk mitigation strategies were overstated [5]. Group 2: Investor Information - Investors who purchased Fluor securities during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested investors can join the class action by visiting the provided link or contacting the law firm directly [3][6]. - A lead plaintiff must be appointed by November 14, 2025, to represent the class in the litigation [1][3]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company at the time [4]. - The firm has consistently ranked highly in securities class action settlements and has recovered hundreds of millions of dollars for investors [4].

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of investors who purchased Savara Inc. securities between March 7, 2024, and May 23, 2025, alleging misleading statements regarding the company's drug application process [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Savara made false statements about the MOLBREEVI Biologics License Application (BLA), indicating it lacked sufficient information for FDA approval [5]. - It is alleged that the FDA was unlikely to approve the MOLBREEVI BLA in its current form, which could delay Savara's submission timeline and increase the need for additional capital [5]. - The lawsuit asserts that these misleading statements caused investors to suffer damages when the true information became public [5]. Group 2: Class Action Participation - Investors who purchased Savara securities during the class period may be entitled to compensation without upfront fees through a contingency fee arrangement [2]. - To join the class action, investors can submit a form online or contact the law firm directly for more information [3][6]. - A lead plaintiff must be appointed by November 7, 2025, to represent the interests of the class members [1][3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest against a Chinese company at the time [4]. - The firm has consistently ranked among the top firms for securities class action settlements since 2013, recovering hundreds of millions for investors [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in handling such cases [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Fly-E Group, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - The Class Period for the Fly-E Group, Inc. securities is from July 15, 2025, to August 14, 2025, inclusive [1]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by November 10, 2025 [2]. Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time [3]. - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of settlements in 2017 and has consistently ranked in the top 4 since 2013 [3]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for clients [3]. Group 3: Case Allegations - The lawsuit alleges that Fly-E Group provided misleading statements regarding the safety of its lithium battery, which negatively impacted E-vehicle sales revenue [4]. - Despite optimistic long-term projections, Fly-E's sales continued to decline, and operating expenses increased, leading to a failure in meeting revenue forecasts [4]. - The lawsuit claims that when the true details were revealed, investors suffered damages due to the misleading information [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Lineage, Inc. common stock during its July 2024 IPO about the September 30, 2025 deadline to become a lead plaintiff in a class action lawsuit [1] Group 1: Class Action Details - Investors who purchased Lineage common stock may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties must move the Court by September 30, 2025, to serve as lead plaintiff [3] - The lawsuit claims that the registration statement was misleading, failing to disclose significant issues affecting Lineage's business operations and financial results [5] Group 2: Allegations Against Lineage - The lawsuit alleges that Lineage experienced a decline in customer demand due to increased cold-storage supply and destocking of excessive inventory built during the COVID-19 pandemic [5] - It is claimed that Lineage implemented unsustainable price increases prior to the IPO, which could not be maintained in the face of weakening demand [5] - The company reportedly could not counteract adverse trends through operational efficiencies or competitive advantages, leading to stagnant or falling revenue, occupancy rates, and rent prices [5] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [4] - The firm has achieved significant settlements for investors, including over $438 million in 2019 alone, and has been ranked highly for its performance in securities class action settlements [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased PubMatic, Inc. securities between February 27, 2025, and August 11, 2025, of the October 20, 2025, deadline to become lead plaintiffs in a class action lawsuit [1] Group 1: Class Action Details - Investors who bought PubMatic securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [2][5] - The lead plaintiff must file a motion with the Court by October 20, 2025, to represent other class members in the litigation [2] Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [3] - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [3] - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, and many attorneys at the firm have received accolades from Lawdragon and Super Lawyers [3] Group 3: Case Allegations - The lawsuit alleges that during the Class Period, PubMatic made false and misleading statements regarding its business operations [4] - A significant demand side platform buyer shifted clients to a new platform, leading to a reduction in ad spend and revenue for PubMatic [4] - The misleading statements resulted in investor damages when the true situation was revealed [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Nutex Health Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1][2]. Group 1: Class Action Details - The Class Period for the Nutex securities is from August 8, 2024, to August 14, 2025, and the lead plaintiff deadline is October 21, 2025 [1]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [2][5]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions [3]. - The firm has achieved significant settlements in the past, including the largest securities class action settlement against a Chinese company at the time [3]. - In 2019, Rosen Law Firm secured over $438 million for investors, showcasing its capability in handling such cases [3]. Group 3: Case Allegations - The lawsuit alleges that Nutex made false and misleading statements regarding its financial practices and internal controls [4]. - Specific claims include that Nutex engaged in fraudulent activities through a third-party vendor, HaloMD, which affected its revenue sustainability [4]. - The lawsuit also states that Nutex overstated its ability to remediate internal control weaknesses, leading to improper accounting of stock-based compensation obligations [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of KinderCare Learning Companies, Inc. about the upcoming lead plaintiff deadline for a class action lawsuit related to the company's October 2024 IPO [1]. Group 1: Class Action Details - Investors who purchased KinderCare common stock may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by October 14, 2025 [3]. - The lawsuit alleges that the registration statement was false and/or misleading, failing to disclose incidents of child abuse and neglect at KinderCare facilities, and that the company did not meet minimum care standards [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].

NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Lantheus Holdings, Inc. (NASDAQ: LNTH) between February 26, 2025 and August 5, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 10, 2025. SO WHAT: If you purchased Lantheus securities duri ...

NEW YORK, Sept. 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Fluor Corporation (NYSE: FLR) between February 18, 2025 and July 31, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than November 14, 2025. SO WHAT: If you purchased Fluor securities during the Class ...